봉독이 연골육종세포의 유전자 발현에 미치는 영향에 대한 Microarray 연구

Microarray Analysis of Gene Expression in Chondrosarcoma Cells Stimulated with Bee Venom

  • 인창식 (경희대학교 한의과대학 침구학교실) ;
  • 고형균 (경희대학교 한의과대학 침구학교실)
  • Yin, Chang-Shik (Department of Acupuncture, College of Korean Medicine, Kyung Hee University) ;
  • Koh, Hyung-Gyun (Department of Acupuncture, College of Korean Medicine, Kyung Hee University)
  • 발행 : 2004.06.25


봉독은 관절염 치료를 비롯한 여러 질환에 그 응용범위가 넓어지고 있으며 기전규명과 새로운 치료효과 개발을 위한 연구가 필요하다. 연골의 파괴는 진행된 각종 관절병증의 공통 병리기전이며 연골세포의 기능이상은 이 기전에 중요한 의미를 지닌다. 사람 연골세포의 특성을 유지하고 있는 HTB-94 연골육종세포를 배양하고 봉독을 처치했을 때의 유전자 발현양상을 microarray를 이용하여 관찰하였다. 대조군에 비해 4배 이상 발현의 차이가 있는 경우를 유의한 것으로 보았을 때 microarray의 344개 유전자중 봉독처치시 발현이 증강되는 유전자는 없었으며 발현이 억제되는 유전자는 interleukin 6 receptor, interleukin 1 alpha, tissue inhibitor of metalloproteinase 1, matrix metalloproteinase 1, tumor necrosis factor (ligand) superfamily, members 4, 8 and 12, and caspases 2, 6, and 10등 35개가 관찰되었다. Microarray를 통한 유전자발현 분석을 통해 관절염에 대한 봉독치료의 기전을 시사하는 유용한 자료를 얻을 수 있었으며 앞으로 보다 넓은 범위에 대한 연구가 필요할 것이다.


  1. Sumikura H, Andersen OK, Drewes AM, Arendt-Nielsen L. A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans.Neurosci Lett. 2003;337(3):147–50.
  2. Nam KW, Je KH, Lee JH, Han HJ, Lee HJ, Kang SK, Mar W. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res. 2003;26(5):383-88.
  3. Kim HW, Kwon YB, Ham TW, Roh DH, Yoon SY, Lee HJ, Han HJ, Yang IS, Beitz AJ, Lee JH. Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord fos expression in rats. J Vet Med Sci. 2003;65(3):349–55.
  4. Orsolic N, Sver L, Verstovsek S, Terzic S, Basic I. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon. 2003;41(7):861–70.
  5. Choi SH, Cho SK, Kang SS, Bae CS, Bai YH, Lee SH, Pak SC. Effect of apitherapy in piglets with preweaning diarrhea. Am J Chin Med. 2003;31(2):321–6.
  6. Jang MH, Shin MC, Lim S, Han SM, Park HJ, Shin I, Lee JS, Kim KA, Kim EH, Kim CJ. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J Pharmacol Sci. 2003;91(2):95–104.
  7. Hwang D, Kim H, Kim C, Kim E. Bee venom induces apoptosis and inhibits COX-2 in human osteosarcoma cell line MG-63. Journal of Korean Acupuncture & Moxibustion Society. 2003;20(3):63–74.
  8. Thornton S, Sowders D, Aronow B, Witte DP, Brunner HI, Giannini EH, Hirsch R. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol. 2002;105(2):155–68.
  9. Kim BS, Seo JC. Microarray analysis of hypoxia-induced changes in gene expression in BV-2 microglial cells. Journal of Korean Acupuncture & Moxibustion Society. 2003;20(4):85-92.
  10. Lee W, Kang S, Koh H. Microarray analysis of CD/cytokine gene expression in human mast cell treated with bee venom. Journal of Korean Acupuncture & Moxibustion Society. 2003;20(5):50-62.
  11. Lee S, Lee H, Baek Y, Kim S, Park J, Hong S, Yang H, Kim K, Lee J, Choi D, Lee D, Lee Y. Effects of bee venom on the pain, edema, and acute inflammatory reactant of rheumatoid arthritis patients. Journal of Korean Acupuncture & Moxibustion Society. 2003;20(2):77–84.
  12. Archer CW, Francis-West P. The chondrocyte. Int J Biochem Cell Biol. 2003;35(4):401–4.
  13. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M, Zafarullah M. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res. 2003;288(1):208–17.
  14. Ibrahim SM, Koczan D, Thiesen H-J. Gene-expression profile of collagen-induced arthritis. J Autoimmun 2002;18(2):159–67.
  15. ATCC(American Type Culture Collection). [cited 2003 Oct 5]. Available from:,5339760,HTB-94&text=sw%20%26%201353&max=20
  16. Ah-Kim H, Zhang X, Islam S, Sofi JI, Glickberg Y, Malemud CJ, Moskowitz RW, Haqqi TM. Tumor necrosis factor $\alpha$ enhances the expression of hydroxyl lyase, cytoplasmic antiproteinase-2 and a dual specificity kinase TTK in human chondrocyte like cells. Cytokine. 2000;12(2):142–50.
  17. Vincenti MP, Brinckerhoff CE. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1$\beta$. Arthritis Res. 2001;3:381–8.
  18. Islam S, Kermode T, Sultana D, Moskowitz RW, Mukhtar H, Malemud CJ, Goldberg VM, Haqqi TM. Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage. 2001;9(8):684–93.
  19. Lee DA, Frean SP, Lees P, Bader DL. Dynamic mechanical compression influences nitric oxide production by articular chondrocytes seeded in agarose. Biochem Biophys Res Commun. 1998;251(2):580–5.
  20. Lee MS, Ikenoue T, Trindade MC, Wong N, Goodman SB, Schurman DJ, Smith RL. Protective effects of intermittent hydrostatic pressure on osteoarthritic chondrocytes activated by bacterial endotoxin in vitro. J Orthop Res. 2003;21(1):117–22.
  21. Amin AR. Gene mining, bioinformatics and functional genomics in human arthritis and inflammatory diseases ex vivo. Drug Dev Res. 2000;49:22–9.<22::AID-DDR4>3.0.CO;2-8
  22. Piecyk M, Anderson P. Signal transduction in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2001;15(5):789–803.
  23. Dayer J-M. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis. Joint Bone Spine 2002;69(2):123–32.
  24. Fischer DC, Siebertz B, van de Leur E, Schiwy-Bochat KH, Graeve L, Heinrich PC, Haubeck HD. Induction of $\alpha$1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint. Arthritis Rheum. 1999;42(9):1936–45.<1936::AID-ANR20>3.0.CO;2-K
  25. Mihara M, Kotoh M, Nishimoto N, Oda Y, Kumagai E, Takagi N, Tsunemi K, Ohsugi Y, Kishimoto T, Yoshizaki K, Takeda Y. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin Immunol. 2001;98(3):319–26.
  26. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4(Supp3):S233–42.
  27. Keul R, Heinrich PC, Muller-newen G, Muller K, Woo P. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis. Cytokine. 1998;10(9):729–34.
  28. Webb GR, Westacott CI, Elson CJ. Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes. Osteoarthritis Cartilage 1998;6(3):167–76.
  29. Lubberts E, Joosten LA, Helsen MM, van den Berg WB. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone. Cytokine. 1998;10(5):361–9.
  30. Lam J, Abu-Amer Y, Nelson CA, Fremont DH, Ross FP, Teitelbaum SL. Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis. Ann Rheum Dis. 2002;61:ii82–3.
  31. Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today. 1998;4(3):130–7.
  32. Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J. 2003;166(2):140–58.
  33. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455–461.
  34. Poole AR, Kobayashi M, Yasuda T, Laverty S, Mwale F, Kojima T, Sakai T, Wahl C, El-Maadawy S, Webb G, Tchetina E, Wu W. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis. 2002;61(Suppl II):ii78–81.
  35. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M. Analysis of 16 different matrix metalloproteinases(MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999;58:691–7.
  36. Mort JS, Billington CJ. Articular cartilage and changes in arthritis matrix degradation. Arthritis Res. 2001;3:337–341.
  37. Mobasheri A. Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses. 2002;58(3):193–7.
  38. Pettersen I, Figenschau Y, Olsen E, Bakkelund W, Smedsrod B, Sveinbjornsson B. Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro. Biochem Biophys Res Commun. 2002;296(3):671–6.
  39. Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002;61(Suppl II):ii96–9.
  40. Ostergaard K, Salter DM, Petersen J, Bendtzen K, Hvolris J, Andersen CB. Expression of $\alpha$ and $\beta$ subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads. Ann Rheum Dis. 1998;57:303–8.
  41. Morales TI. The insulin-like growth factor binding proteins in uncultured human cartilage: increases in insulin-like growth factor binding protein 3 during osteoarthritis. Arthritis Rheum. 2002;46(9):2358–67.
  42. Eviatar T, Kauffman H, Maroudas A. Synthesis of insulin-like growth factor binding protein in vitro in human articular cartilage cultures. Arthritis Rheum. 2003;48(2):410–7.
  43. Heemskerk VH, Daemen MA, Buurman WA. Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation. Cytokine Growth Factor Rev. 1999;10(1):5–14.